Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by Bull4u2on Dec 20, 2017 8:09pm

131 Views

Post# 27200873

Financing in 2018

Now that SVA has their FDA approval, I would bet they will be back next year to raise more money.
These speculative biotech stocks take a long long time to before results come to fruition. It would be nice to see a major house start to cover them. In the big board world Mackie is a very small fish.
RBC or BMO would be a nice addition.

Bullboard Posts

Gold vs. bitcoin, where should you invest?